Hypertriglyceridemia 1 (HYTG1)

Hypertriglyceridemia 1, also known as hypertriglyceridemia, is related to apolipoprotein c-ii deficiency and lipase deficiency, combined, and has symptoms including hypertriglyceridemic waist An important gene associated with Hypertriglyceridemia 1 is APOA5 (Apolipoprotein A5), and among its related pathways/superpathways are Metabolism and Olfactory Signaling Pathway. The drugs Metformin and Ciprofibrate have been mentioned in the context of this disorder. Affiliated tissues include heart and liver, and related phenotypes are hypertriglyceridemia and glucose intolerance